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OBJECTIVES: The use of Comparative Effectiveness Research (CER) is intended to 
help patients and providers make sound health care and treatment decisions. 
However, little is known about the impact of CER on financial incentives for 
medical innovation and, ultimately, the health of future generations. Using a 
microsimulation approach, we analyze the impacts of potential CER policies on 
biomedical innovation and population health in the United States and Europe. 
METHODS: We selected three clinical scenarios that reflect broad trends for 
assessing the impacts of CER policies on innovation returns: growth in 
personalized medicine; increasing demand for head-to-head trials; and changes 
in size and complexity of trials. We estimated the impact on development costs, 
revenue, and the timing of returns (lags between development, approval, and 
reimbursement coverage). These scenario-specific impacts were then 
generalized to the US and European markets, and a range of estimated effects of 
CER policies were compiled. We simulated the impact of changes in current 
innovation incentives on producer output and the health of future populations in 
year 2060 using the Future Elderly Model (FEM). RESULTS: Under most scenarios, 
CER policies would have negative impacts on innovation, and lead to substantial 
reductions in population life expectancy. Population life expectancy was 
estimated to be reduced by 14.1% (range, 9.0% to 15.6%) by 2060 due to CER 
policies related to trends in personalized medicine, 4.4% (-8.1% to +5.5%) related 
to active comparators, and 7.4% (-11.4% to +10.2%) related to increased trial 
complexity. Only with multiple innovation-friendly assumptions (such as trial 
cost reductions, relatively high price increases, and large market size growth 
driven by personalized medicine), do CER policies generate increases in 
innovation output and corresponding social value. CONCLUSIONS: The potential 
long-run consequences of CER on innovation and future health calls for careful 
consideration of CER policies that encourage and incentivize innovation.  
 




PRESCRIBING PATTERN OF CLINICIANS IN PRIVATE HEALTH FACILITIES: AN 
ASSESSMENT FOR RATIONAL DRUG USE  
Ahmad M1, Akhtar M1, Ahmad I2, Jan SU3 
1The Islamia University of Bahawalpur, Bahawalpur, Pakistan, 2The Islamia University of 
Bahawalpur, Bahawalpur, Punjab, Pakistan, 3University of Balochistan, Quetta, Pakistan  
OBJECTIVES: The current study was aimed to explore the prescribing pattern of 
clinicians practicing at their private clinics for evaluation of rational drug use. 
METHODS: Eight community pharmacies were selected to collect prescriptions 
randomly and studied for the conformity of the prescriptions issued by clinicians 
with the general format of a typical prescription and rational drug use, following 
WHO guidelines. The four months study was comprised of 1230 total number of 
prescriptions. RESULTS: Majority of the prescriptions did not conform to the 
format of a typical prescription. Twenty three percent (23.2%) of total 
prescriptions were not included the age of the patient out of which were 30.1% of 
pediatric prescriptions. Superscription was not mentioned in 10.9% of the 
prescriptions. Inscription, subscription and signatura were inadequate in 33.4%, 
22.6% and 29.2% of the prescriptions, respectively. Seven percent (7%) of total 
prescriptions were computer generated. The average number of drugs per 
prescription was found to be 3.4. Generic prescribing was very low at 13.5%. 
Antibiotics (39.9%) were the highest prescribed drugs while 
analgesics/antipyretics, antihypertensive, vitamin preparations, antiulcer, 
anxiolytics and antihistaminic were commonly prescribed drugs. About 19.3% of 
the encounters had at least one injection prescribed. More than half (56.2%) of 
the prescribed drugs were from the National Essential Drugs List of Pakistan. 
CONCLUSIONS: A number of prescriptions do not conform to ideal prescribing 
pattern and lack in their rationality. Overuse of antibiotics & injections, small 
number of generic prescribing and polypharmacy were observed in private 
health facilities in Pakistan. The current study can help to recognize the 
dilemma in therapeutic decision making and to improve the prescribing skills by 
planning for educational interventions.  
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OBJECTIVES: To determine the practice of prescribing medicines by specialized 
physicians in Basrah. METHODS: A drug utilization study was conducted among 
pharmacies’ attendees while purchasing their treatments in Basrah, southern 
governorate of Iraq, from June to August 2011. A stratified sample method was 
adopted for selecting community pharmacies. Prescriptions written by 
specialized physicians were collected and analyzed according to WHO standard 
treatment guidelines. RESULTS: The data were gathered from 896 prescriptions. 
Unfair number of drugs was prescribed in which the mean number of drugs in a 
single prescription was 4.0 (+1.8). The value of prescribing indicators was more 
than the WHO standard indicators. Most of the prescribed medicines (87%) have 
been written in their generic names. Moreover, the frequently prescribed 
medicines were antibiotics (45.7%); anxiolytics (19.3%); and corticosteroids (12%). 
CONCLUSIONS: Physicians’ adherence to the standard prescribing guidelines 
was poor in this study. Although the affordability of medicines was good; the 
practice of prescribing medicines need to be appropriate. Implementing 
appropriate administrative strategies to improve the current prescribing pattern 
in Basrah; as well as, patient-educational programs concerning the treatment 
they receive are warranted. In addition, further studies should be undertaken in 
other provinces of Iraq in order to understand the country level of prescribing 
medicines.  
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OBJECTIVES: To develop and validate a 30-day readmission risk prediction model 
for implementation in a site-of-service personalized medicine tool. The 
readmission risk score (RRS) is easily interpretable by providers and adaptable to 
variability in input data. METHODS: The RRS was developed and validated using 
administrative claims linked to additional data for commercial and Medicare 
Advantage (MA) enrollees hospitalized between 01Jan2007 and 30Sep2011. Blocks 
of candidate predictors (demographics, comorbidities, social determinants of 
health, mental health conditions, pre-admission service utilization, admission 
details) were used in logistic regression predicting readmission. Main and 
interaction effects were examined within blocks and blocks were combined in 
step-wise fashion. Goodness-of-fit was assessed with Wald chi-square and c-
statistics. Sub-models for each combination of blocks accommodated variations 
in available data. The ROC distribution was used to create an indicator of the 
utility of each patients’ RRS: green for best predictive power, yellow, and red for 
predictive power too low for use by the care manager in prioritizing patient 
outreach. RESULTS: Overall 30-day readmission rate among hospitalized 
subjects (N=973,316, 53% female, mean age 55, 8% MA, 13% non-white, mean 
Charlson score: 1.66) was 7.5%. When subjects with a predicted RRS ≥ 0.10 were 
classified as ‘readmitted,’ model statistics were: c-statistic=0.6735, 
sensitivity=0.3801, specificity=0.8426. Sub-models were classified as having low, 
moderate, or best predictive ability (c-statistic ranges: 0.5644–0.6002; 0.6183–
0.6483; 0.6583–0.6725 respectively). CONCLUSIONS: The RRS achieved high 
specificity; sensitivity and overall c-statistic were not optimal. Predictive ability 
of the index may be improved in the next phase when both claims and electronic 
medical records data will be used to reconstruct the RRS. The RRS allows care 
systems to calculate a risk score at the site-of-service with even a minimum set 
of data. Providers are presented with the strength of the score so that they may 
apply limited resources with data-driven intelligence.  
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OBJECTIVES: In 2010, Medicare spent over $117 billion in hospital-related expenses. 
The new Accountable Care Organization (ACO) model promises to reduce some of 
these costs by allowing providers to financially benefit from any savings they can 
deliver while also maintaining strong quality with an eye towards prevention of 
costly hospitalizations. In the short-term, specifically the 3-year trial period, ACOs 
will need to prioritize their initiatives and target areas where they can be most 
successful and expedient in reducing costs. We aim to understand whether the 
CMS-mandated quality benchmarking has the potential to drive a reduction in 
common and costly hospitalizations through increased diagnostic tests, better care 
coordination, and management of patients with chronic diseases in the short-term. 
METHODS: This research examines the alignment between 1) the CMS-mandated 
ACO quality metrics, and 2) the most utilized and costly DRG codes (2010 MedPAR 
data). We also examine the evidence to support the possibility that a reduction in 
hospitalizations within these top DRG categories can be achieved. RESULTS: 
Analyses indicate that quality metrics are aligned and can drive reductions in 60% 
of the top 20 DRG claim categories. These costly DRGs include those for the 
treatment of chronic obstructive pulmonary disease, renal failure, heart failure, 
septicemia or severe sepsis, psychoses, and rehabilitation days after 
hospitalization. Together, these DRG claims cost Medicare over $21 billion in 
hospital-related expenses in 2010. CONCLUSIONS: If ACOs diligently work to 
achieve their quality benchmarks, they have the potential to deliver savings to CMS 
by reducing costs through better outpatient care and hospitalization prevention 
strategies within the top 20 DRG claim categories. However, it remains unclear as to 
what degree savings can be achieved.  
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OBJECTIVES: It has been argued that medical specialization has positive benefits 
for health outcomes. The objective of this study is to assess whether or not 
specialized, single-service hospital organizations outperform generalist ones 
METHODS: We collected data from all 169 hospital organizations in England that 
admit adult inpatients. These were observed over two financial years (April 2005-
March 2007), producing a total of 338 observation points. Mean patient 
satisfaction scores were used to measure clinical quality, while financial 
performance was measured by Return on Assets (ROA). Random effects panel 
regression analysis with control variables was employed. RESULTS: It is observed 
